1-Methyl-1,2,3,6-Tetrahydropyridine Hydrochloride CAS:73107-26-3

1-Methyl-1,2,3,6-tetrahydropyridine hydrochloride is primarily utilized in neuroscience research to induce parkinsonism in animal models, mimicking aspects of Parkinson's disease pathology. By selectively targeting dopaminergic neurons, it facilitates the study of disease progression and the evaluation of novel therapeutic strategies. Moreover, its application extends to organic synthesis, where it serves as a precursor for the preparation of various heterocyclic compounds with pharmaceutical relevance. In laboratory settings, researchers employ 1-Methyl-1,2,3,6-tetrahydropyridine hydrochloride in organic transformations to access diverse chemical scaffolds for drug discovery and development. Its controlled reactivity and compatibility with synthetic methodologies enable the synthesis of molecules with potential pharmacological activities, supporting efforts to identify new treatments for neurological disorders and other conditions. Additionally, its availability from reputable suppliers ensures consistent quality and supply, facilitating ongoing research endeavors worldwide and contributing to advancements in neuroscience and drug discovery.